Vertex’s Termination for Convenience. Vertex will be entitled to terminate this Agreement as a whole, or terminate this Agreement in part with respect to a particular Collaboration Program, for convenience by providing CRISPR 90 days’ written notice of such termination; provided, however, that if any termination under this Section 11.2.1 applies to a Product for which Vertex has received Marketing Approval, Vertex will provide CRISPR no less than 270 days’ notice of such termination.
Appears in 4 contracts
Samples: Strategic Collaboration, Option and License Agreement, Strategic Collaboration, Option and License Agreement (CRISPR Therapeutics AG), Strategic Collaboration, Option and License Agreement (CRISPR Therapeutics AG)
Vertex’s Termination for Convenience. Vertex will be entitled to terminate this Agreement as a wholefor convenience, in its entirety or terminate this Agreement in part with respect to a particular Collaboration Programone or more Shared Product(s), for convenience by providing CRISPR 90 days’ written notice of such termination; provided, however, that if any termination under this Section 11.2.1 applies 17.2.1 with respect to a Shared Product for which Vertex occurs after such Shared Product has received Marketing Approval, Vertex will provide CRISPR no less than 270 days’ written notice of such termination.
Appears in 2 contracts
Samples: Joint Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Joint Development and Commercialization Agreement (CRISPR Therapeutics AG)
Vertex’s Termination for Convenience. Vertex will be entitled to terminate this Agreement as a wholefor convenience, in its entirety or terminate this Agreement in part with respect to a particular Collaboration Programone or more Shared Product(s), for convenience by providing CRISPR 90 days’ written notice of such termination; provided, however, that if any termination under this Section 11.2.1 applies 14.2.1 with respect to a Shared Product for which Vertex occurs after such Shared Product has received Marketing Approval, Vertex will provide CRISPR no less than 270 days’ written notice of such termination.
Appears in 1 contract
Samples: Joint Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)